Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (3): 454-459.doi: 10.1007/s40242-013-2490-3

• Articles • Previous Articles     Next Articles

Design and Synthesis of Hydrazine and Oxadiazole-containing Derivatives of Sorafenib as Antitumor Agents

WANG Yuan-you1, LIU Jian-zhen1, YU Xiao-yue1, YANG De-zhi1, ZHANG Lin-na2, ZHAO Gui-sen1   

  1. 1. Key Laboratory of Chemical Biology, Ministry of Education, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China;
    2. Qilu Hospital, Shandong University, Jinan 250012, P. R. China
  • Received:2012-12-10 Revised:2013-03-01 Online:2013-06-01 Published:2013-05-15
  • Contact: Gui-Sen ZHAO E-mail:linnazhang62@yahoo.com.cn; guisenzhao@sdu.edu.cn
  • Supported by:

    Supported by the National Natural Science Foundation of China(No.21072115) and the Student Training Programs for Innovation of Shandong University, China(No.201210422076).

Abstract:

A series of hydrazine and oxadiazole analogs of Sorafenib was designed, synthesized and characterized by proton nuclear magnetic resonance(1H NMR) spectrometry and high resolution mass spectrometry(HRMS). The antiproliferative activities of these compounds against human colorectal carcinoma(HCT-116) and human breast cancer (MDA-MB-231) tumor cell lines were evaluated in vitro by MTT method[MTT=3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide]. The bioassay results suggest that most of the synthesized compounds have antitumor potential to HCT-116 cell line compared with MDA-MB-231 cell line. Compounds 8a,8b,8d, 8e,9f and 9j competitive with Sorafenib demonstrated antiproliferative activities on HCT-116 cell line.

Key words: Sorafenib analog, Antiproliferative activity, Antitumor agent